Search
for
Sort by
Research 601–630 of 1000+
- Signal detection between 5-alpha reductase inhibitors and the risk of suicidality and depression: an international pharmacovigilance analysis
- Pharmacological Role and Clinical Applications of 5α-Reductase Inhibitors-Review Article for Pharmacists and Healthcare Professionals
- An exploratory analysis of 5‐alpha reductase inhibitors and risk of opioid use disorder among male Medicare beneficiaries receiving prescription opioid medications
- MP31-04 HOW DO 5-ALPHA-REDUCTASE INHIBITORS CHANGE PSA DENSITY IN PATIENTS ON ACTIVE SURVEILLANCE?
- NEW PROPRIETARY BRANDS: Gabapentin
- New drugs: Agalsidase beta
- NEW FORMULATIONS: Sodium cromoglycate
- Application of 2-Chloro-7-Nitrobenzo-2-Oxa-1, 3-Diazol (NBDCL) for Spectrophotometric Determination of Finasteride in Pharmaceutical Formulation
- Effects of 5-?±-Reductase Inhibitor (Finasteride) on Per Operative Blood Loss in Patients with BPH undergoing TURP
- Macular Abnormalities Associated With 5α-Reductase Inhibitor
- O que sabemos sobre os inibidores da 5 alfa redutase?
- The Rationale for Inhibiting 5α-Reductase Isoenzymes in the Prevention and Treatment of Prostate Cancer
- Polycystic Ovary Syndrome
- Adverse effects of common medications on male fertility
- Dermatology of androgen-related disorders
- Frontal Fibrosing Alopecia: An Update on Pathogenesis, Diagnosis, and Treatment
- Anti-inflammatory, cyclooxygenase inhibitory and antioxidant activities of standardized extracts of Tridax procumbens L.
- Medical therapy for frontal fibrosing alopecia: A review and clinical approach
- Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects
- Clinical relevance of testosterone and dihydrotestosterone metabolism in women
- Hypersensitivity Reactions to Anticoagulant Drugs
- Hormone therapy in acne
- Frontal fibrosing alopecia: a case series of 65 patients seen in a single Italian centre
- Enhanced effect of fibroblast growth factor-2-containing dalteparin/protamine nanoparticles on hair growth
- A medicinal and edible formula YH0618 ameliorates the toxicity induced by Doxorubicin via regulating the expression of Bax/Bcl-2 and FOXO4
- Role of 5 alpha-reductase inhibitors in the management of prostate cancer
- Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia
- THERAPEUTIC HOTLINE: Treatment of androgenic alopecia with finasteride may result in a high grade prostate cancer in patients: fact or fiction?
- Co-administration of 5α-reductase Inhibitors Worsens the Adverse Metabolic Effects of Prescribed Glucocorticoids
- Anti-inflammatory and anti-hyperplastic effect of Bazhengsan in a male rat model of chronic nonbacterial prostatitis